Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenobarbital adjunctive therapy in partial onset seizures
NCT01284556Phase 3Completed
- Sponsor
- Roxane Laboratories
- Start
- Nov 2010
- Primary completion
- Jan 2013
- Modality
- Allosteric Modulators
- Countries
- 2
01
Overview
A Phase 3 trial of phenobarbital in focal onset seizure, sponsored by Roxane Laboratories. Started Nov 2010; status: completed.
02
Drugs
phenobarbital
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT01284556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01284556.